161 related articles for article (PubMed ID: 34221185)
1. A Five-Gene Prognostic Nomogram Predicting Disease-Free Survival of Differentiated Thyroid Cancer.
Ruchong P; Haiping T; Xiang W
Dis Markers; 2021; 2021():5510780. PubMed ID: 34221185
[TBL] [Abstract][Full Text] [Related]
2. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
[TBL] [Abstract][Full Text] [Related]
3. A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer.
Ding Y; Li P; Wang W; Liu F
Dis Markers; 2022; 2022():8735551. PubMed ID: 36193505
[TBL] [Abstract][Full Text] [Related]
4. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene
Ju G; Zhang L; Guo W; Wang H; Zhang X; Mu Z; Sun Y; Sun D; Diao H; Miao S; Chen Y; Xing T; Liang J; Lin Y
Dis Markers; 2022; 2022():1686316. PubMed ID: 37223105
[TBL] [Abstract][Full Text] [Related]
6. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Wu M; Yuan H; Li X; Liao Q; Liu Z
Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
[No Abstract] [Full Text] [Related]
8. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
Wang T; Tian K; Ji X; Song F
Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma.
Tang J; Jiang S; Gao Q; Xi X; Gao L; Zhao R; Lai X; Zhang B; Jiang Y
Cancer Med; 2021 Aug; 10(16):5488-5498. PubMed ID: 34240816
[TBL] [Abstract][Full Text] [Related]
10. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
12. Establishment of a predictive nomogram for differentiated thyroid cancer: an inpatient-based retrospective study.
Du J; Li W; Zhao X; Shen C; Zhang X
Endokrynol Pol; 2023; 74(6):. PubMed ID: 37994582
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of a prognostic nomogram to predict long-term survival in non-metastatic colorectal cancer patients].
Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):654-659. PubMed ID: 28643310
[TBL] [Abstract][Full Text] [Related]
14. A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma.
Liu M; Tong L; Liang B; Song X; Xie L; Peng H; Huang D
Front Oncol; 2021; 11():587548. PubMed ID: 33767977
[TBL] [Abstract][Full Text] [Related]
15. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
17. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
19. Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model.
Li C; Xu F; Huang Q; Han D; Zheng S; Wu W; Zhao F; Feng X; Lyu J
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34159295
[TBL] [Abstract][Full Text] [Related]
20. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Wu G; Zhang M
BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]